Edition:
United States

ARYx Therapeutics Inc (ARYX.PK)

ARYX.PK on OTC Markets Group

0.00USD
3:29pm EDT
Change (% chg)

$-0.00 (-1.33%)
Prev Close
$0.00
Open
$0.00
Day's High
$0.00
Day's Low
$0.00
Volume
325
Avg. Vol
16,069
52-wk High
$0.01
52-wk Low
$0.00

Chart for

About

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of... (more)
No analyst recommendations are available for .

Overall

Beta: -5.32
Market Cap(Mil.): $0.10
Shares Outstanding(Mil.): 33.46
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.87 15.95
EPS (TTM): -- -- --
ROI: -- 14.31 15.19
ROE: -- 15.61 13.87

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $131.17 -0.22
Pfizer Inc. (PFE.N) $35.51 -0.45
Novartis AG (NOVN.S) CHF83.85 +0.40
Sanofi SA (SASY.PA) €84.64 --
AstraZeneca plc (AZN.L) 4,930.00 +18.00
Bayer AG (BAYGn.DE) €111.90 +1.80
Bayer AG (BAYE.F) -- --
3M Co (MMM.N) $210.73 -0.03
Bristol-Myers Squibb Co (BMY.N) $63.19 -0.17
Bristol-Myers Squibb Co (BMYMP.PK) $1,050.00 --

Earnings vs. Estimates